BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2810016)

  • 1. The rapid evaluation of intestinal bacterial growth using a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
    Maeda Y; Takahashi M; Tashiro H; Akazawa F
    J Pharmacobiodyn; 1989 May; 12(5):272-80. PubMed ID: 2810016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basic studies on ursodeoxycholyl-para-aminobenzoic acid for evaluation of intestinal microflora.
    Takahashi M; Maeda Y; Tashiro H; Akazawa F; Okajima M; Yoshioka S; Matsugu Y; Toyota K; Masaoka Y
    Scand J Gastroenterol; 1991 Jun; 26(6):577-88. PubMed ID: 1862298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new simple test for evaluation of intestinal bacteria.
    Takahashi M; Maeda Y; Tashiro H; Eto T; Goto T; Sanada O
    World J Surg; 1990; 14(5):628-34; discussion 635. PubMed ID: 2238664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrolysis and absorption of a conjugate of ursodeoxycholic acid with para-aminobenzoic acid.
    Maeda Y; Takahashi M
    J Pharmacobiodyn; 1989 Dec; 12(12):744-53. PubMed ID: 2635732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the conjugate of disulphated ursodeoxycholic acid with p-aminobenzoic acid for the detection of intestinal bacteria.
    Takahashi M; Konishi T; Maeda Y; Matsugu Y; Akazawa F; Eto T; Okajima M; Uchida K; Masaoka Y; Okada K
    Gut; 1993 Jun; 34(6):823-8. PubMed ID: 8314517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basic studies on the utility of ursodeoxycholic acid derivatives for clinical medicine].
    Konishi T
    Yakugaku Zasshi; 2000 Jan; 120(1):1-15. PubMed ID: 10655778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newly synthesized compound, PABA-ursodeoxycholic acid, for evaluation of intestinal bacteria.
    Takahashi M; Maeda Y; Matsuno K; Tamura H; Furuyashiki S; Harada M
    Hiroshima J Med Sci; 1987 Dec; 36(4):377-81. PubMed ID: 3502343
    [No Abstract]   [Full Text] [Related]  

  • 8. Basic studies on 5-(7-hydroxy-3-O-phosphonocholyl)aminosalicylic acid for the evaluation of microbial overgrowth.
    Konishi T; Takahashi M; Ohta S
    Biol Pharm Bull; 1997 Apr; 20(4):370-5. PubMed ID: 9145212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The ursodeoxycholic acid-p-aminobenzoic acid test in the diagnosis of small bowel bacterial overgrowth syndrome].
    Kiss Z; Wölfling J; Csáti S; Nagy F; Lonovics J; Schneider G
    Orv Hetil; 1997 May; 138(20):1255-8. PubMed ID: 9244859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new substrate for the rapid evaluation of enteric microbial overgrowth.
    Wolgemuth RL; Hanson KM; Zassenhaus PH
    Am J Dig Dis; 1976 Sep; 21(9):821-6. PubMed ID: 961679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ursodeoxycholic acid-p-aminobenzoic acid deconjugation test, a new tool for the diagnosis of bacterial overgrowth syndrome.
    Kiss ZF; Wölfling J; Csáti S; Nagy F; Wittmann T; Schneider G; Lonovics J
    Eur J Gastroenterol Hepatol; 1997 Jul; 9(7):679-82. PubMed ID: 9262976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpancreatic hydrolysis of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (PABA peptide) in the rat small intestine.
    Sterchi EE; Green JR; Lentze MJ
    J Pediatr Gastroenterol Nutr; 1983; 2(3):539-47. PubMed ID: 6352892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal absorption and metabolism of homoursodeoxycholic acid in rats.
    Kuramoto T; Moriwaki S; Kawamoto K; Hoshita T
    J Pharmacobiodyn; 1987 Jul; 10(7):309-16. PubMed ID: 3694424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug elimination function of rat small intestine: metabolism and intraluminal excretion.
    Yasuhara M; Kurosaki Y; Kimura T; Sezaki H
    Biochem Pharmacol; 1984 Oct; 33(20):3131-6. PubMed ID: 6333241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth.
    Maeda Y; Murakami T
    Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and intestinal metabolism of ursodeoxycholic acid conjugate with an antiinflammatory agent, 5-aminosalicylic acid.
    Batta AK; Tint GS; Xu G; Shefer S; Salen G
    J Lipid Res; 1998 Aug; 39(8):1641-6. PubMed ID: 9717724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, intestinal absorption and metabolism of sarcosine conjugated ursodeoxycholic acid.
    Kimura M; Hatono S; Une M; Fukuoka C; Kuramoto T; Hoshita T
    Steroids; 1984 Jun; 43(6):677-87. PubMed ID: 6533845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary choloyl-PABA excretion in diagnosing small intestinal bacterial overgrowth: evaluation of a new noninvasive method.
    Bardhan PK; Feger A; Kogon M; Muller J; Gillessen D; Beglinger C; Gyr N
    Dig Dis Sci; 2000 Mar; 45(3):474-9. PubMed ID: 10749320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-pancreatic hydrolysis of N-benzoyl-l-tyrosyl-p-aminobenzoic acid (PABA-peptide) in the human small intestine.
    Sterchi EE; Green JR; Lentze MJ
    Clin Sci (Lond); 1982 May; 62(5):557-60. PubMed ID: 7042181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport characteristics of p-acetamidobenzoic acid in brush border membrane of rat small intestine.
    Yasuhara M; Kimura T; Sezaki H
    J Pharmacobiodyn; 1983 Nov; 6(11):888-91. PubMed ID: 6607987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.